News
Planet Fitness Misses Q1 Earnings & Revenue Mark, Retains '25 View
Planet Fitness, Inc. PLNT reported lower-than-expected first-quarter 2025 results, wherein adjusted earnings and revenues missed the Zacks Consensus Estimate. However, both metrics increased on a
Implied Volatility Surging for TORM (TRMD) Stock Options
Investors in TORM plc TRMD need to pay close attention to the stock based on moves in the options market lately. That is because the July 18, 2025 $5 Callhad some of the highest implied volatility
Adtalem Stock Gains on Q3 Earnings & Revenue Beat, FY25 View Up
Adtalem Global Education Inc. ATGE posted impressive third-quarter fiscal 2025 results, wherein adjusted earnings and revenues topped the Zacks Consensus Estimate and increased year over year.The
Curtiss-Wright Q1 Earnings Outpace Estimates, '25 View Raised
Shares of Curtiss-Wright Corporation CW gained 4.4% to reach $378.03 on May 8, following its first-quarter 2025 earnings release.
The company reported adjusted earnings per share (EPS) of $2.82
The Zacks Analyst Blog Highlights AngloGold Ashanti, Barrick Mining and Gold Fields
For Immediate Release
Chicago, IL – May 9, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events
Tetra Tech Q2 Earnings & Revenues Top Estimates, Increase Y/Y
Tetra Tech, Inc. TTEK reported second-quarter fiscal 2025 (ended March 2025) adjusted earnings of 33 cents per share, which surpassed the Zacks Consensus Estimate of 31 cents. The company’s adjusted
The Zacks Analyst Blog Highlights NVIDIA, Abbott Laboratories, Linde and Tredegar
For Immediate Release
Chicago, IL – May 9, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events
Canaan (CAN) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Canaan (CAN) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a
Flowers Foods (FLO) Reports Next Week: What to Know Ahead of the Release
Wall Street expects flat earnings compared to the year-ago quarter on higher revenues when Flowers Foods (FLO) reports results for the quarter ended March 2025. While this widely-known consensus
Best Momentum Stocks to Buy for May 9th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 9th:
BioCryst Pharmaceuticals, Inc. BCRX: This biotechnology company has a Zacks Rank #1
The Zacks Analyst Blog Highlights Tesla, NIO, Li Auto and XPeng
For Immediate Release
Chicago, IL – May 9, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events
Wall Street Analysts Think Lions Gate (LGF.A) Could Surge 27.47%: Read This Before Placing a Bet
Lions Gate Entertainment (LGF.A) closed the last trading session at $8.59, gaining 10.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets
Wall Street Analysts Think Priority Technology (PRTH) Could Surge 90.76%: Read This Before Placing a Bet
Priority Technology (PRTH) closed the last trading session at $6.71, gaining 2.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Wall Street Analysts Think Roku (ROKU) Could Surge 44.83%: Read This Before Placing a Bet
Roku (ROKU) closed the last trading session at $61.36, gaining 3.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Does Nuvectis Pharma (NVCT) Have the Potential to Rally 108.79% as Wall Street Analysts Expect?
Nuvectis Pharma, Inc. (NVCT) closed the last trading session at $9.22, gaining 8.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Wall Street Analysts See a 71.07% Upside in Pros Holdings (PRO): Can the Stock Really Move This High?
Pros Holdings (PRO) closed the last trading session at $16.87, gaining 2.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Wall Street Analysts See a 219.98% Upside in Syndax (SNDX): Can the Stock Really Move This High?
Syndax Pharmaceuticals (SNDX) closed the last trading session at $11.01, gaining 4.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set
How Much Upside is Left in Astrazeneca (AZN)? Wall Street Analysts Think 27.89%
Astrazeneca (AZN) closed the last trading session at $67.30, gaining 3.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Does Braze (BRZE) Have the Potential to Rally 52.61% as Wall Street Analysts Expect?
Shares of Braze, Inc. (BRZE) have gained 10.8% over the past four weeks to close the last trading session at $33.66, but there could still be a solid upside left in the stock if short-term price
Does Copa Holdings (CPA) Have the Potential to Rally 49.43% as Wall Street Analysts Expect?
Copa Holdings (CPA) closed the last trading session at $100.68, gaining 19% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
How Much Upside is Left in Altimmune (ALT)? Wall Street Analysts Think 285.86%
Shares of Altimmune, Inc. (ALT) have gained 39.4% over the past four weeks to close the last trading session at $5.80, but there could still be a solid upside left in the stock if short-term price
Does Amneal (AMRX) Have the Potential to Rally 54.16% as Wall Street Analysts Expect?
Shares of Amneal Pharmaceuticals (AMRX) have gained 7% over the past four weeks to close the last trading session at $7.46, but there could still be a solid upside left in the stock if short-term


